Results 151 to 160 of about 6,338,079 (289)
Evaluation of Xpert MTB/RIF Assay, MTB Culture and Line Probe Assay for the Detection of MDR Tuberculosis in AFB Smear Negative Specimens. [PDF]
Lama C +7 more
europepmc +1 more source
Selected primer and probe sequences for each multi-parallel assay.
Selected primer and probe sequences for each multi-parallel assay.
James S. McCarthy (168665) +6 more
core +1 more source
Matched spatial transcriptomics and single‐nuclei RNA‐seq were generated for anaplastic and BRAFV600E papillary thyroid cancers revealing generic and tumor‐specific states occurring in cancer cells and in the tumor microenvironment. In this context, cancer dedifferentiation mirrored organoid maturation through ordered thyroid marker gain/loss ...
Adrien Tourneur +11 more
wiley +1 more source
Utility of line probe assay in detecting drug resistance and the associated mutations in patients with extrapulmonary tuberculosis in Addis Ababa, Ethiopia. [PDF]
Diriba G +16 more
europepmc +1 more source
Primer and probe sequences for the multiplex genotyping assay.
Primer and probe sequences for the multiplex genotyping assay.
Tanny J. K. van der Reijden (711604) +7 more
core +1 more source
The proposed mechanism of action for the CDK12/13 inhibitor and cyclin K degrader, CT7439. CDK12/13 inhibition interrupts transcription elongation, leading to increased DNA damage that results in cell death. This agent is a potentially novel treatment option for patients with colorectal cancer. Created in BioRender. Cyclin‐dependent kinase (CDK) 12 and
Wylie K. Watlington +10 more
wiley +1 more source
Early detection of Pre-XDR TB with line probe assay in a high TB burden country. [PDF]
Madukaji L +11 more
europepmc +1 more source
Lists of assay ID and probe sequence for RT-PCR.
Lists of assay ID and probe sequence for RT-PCR.
Yi-Chun Chen (189669) +4 more
core +1 more source
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq +8 more
wiley +1 more source

